Monitoring tuberculosis treatment outcome: Analysis of national surveillance data from a clinical perspective

Thorax

Volumn 63, Issue 5, 2008, Pages 440-446

  Ditah, I C ^a   Reacher, M ^b   Palmer, C ^a   Watson, J M ^b   Innes, J ^c   Kruijshaar, M E ^b   Luma, H N ^e   Abubakar, I ^b,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e YAOUNDÉ GENERAL HOSPITAL   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CALCULATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

ADULT; AGE DISTRIBUTION; AGED; ANTITUBERCULAR AGENTS; EPIDEMIOLOGIC METHODS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; SEX DISTRIBUTION; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 43749092580     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.073916     Document Type: Article

References (19)

1. World Health Organization. Global tuberculosis control: Surveillance, planning and financing. WHO report. WHO/HTMAB/2006.362. Geneva: WHO, 2006.
2. World Health Organization. Treatment of tuberculosis: Guidelines for National Programmes, 3rd Edn. WHO/CDC/TB/2003.313. Geneva: WHO, 2003.
3. Tuberculosis Section. Focus on Tuberculosis: 2006 Surveillance Report, England, Wales and Northern Ireland. London: Health Protection Agency, 2006.
4. Veen J, Raviglione M, Rieder HL, et al. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998;12:505-10.
5. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002;19:765-75.
6. Tuberculosis Section Respiratory Diseases Department Communicable Disease Surveillance Centre Health Protection Agency. First Annual Report on Tuberculosis Treatment Outcome Surveillance in England, Wales and Northern Ireland: Outcome Results on Tuberculosis Cases Reported in 2001. London: Tuberculosis Section Respiratory Diseases Department Communicable Disease Surveillance Centre Health Protection Agency. 2004.
7. Farah MG, Tverdal A, Steen TW, et al. Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health 2005;5:14.
8. Faustini A, Hall AJ, Perucci CA. Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J 2005;26:503-10.
9. Diel R, Niemann S. Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001. Int J Tuberc Lung Dis 2003;7:124-31.
10. Ormerod LP, Prescott RJ. The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998. Clin Med 2003;3:57-61.
11. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians, 2006.
12. Krejbich F, Trnka L, Mazankova V. Tuberculosis in the Czech Republic in 2002. Cas Lek Cesk 2003;142:746-50.
13. Trnka L, Dankova D, Krejbich F. Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country? Int J Tuberc Lung Dis 2001;5:250-6.
14. Lillebaek T, Poulsen S, Kok-Jensen A. Tuberculosis treatment in Denmark: treatment outcome for all Danish patients in 1992. Int J Tuberc Lung Dis 1999;3:603-12.
15. Chapman RC, Claydon SM. Mycobacterium tuberculosis: a continuing cause of sudden and unexpected death in west London. J Clin Pathol 1992;45:713-15.
16. Antoine D, Maguire H, Story A. Epidemiology and response to the growing problem of tuberculosis in London. Euro Surveill 2006;11:25-8.
17. Terris M. Relation of economic status to tuberculosis mortality by age and sex. Am J Public Health 1948;38:1061-70.
18. Fielder JF, Chaulk CP, Dalvi M, et al. A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates. Int J Tuberc Lung Dis 2002;6:1114-17.
19. Conaty SJ, Dart S, Hayward AC, et al. Reasons for low reported treatment success in notified tuberculosis patients from a London hospital according to new outcome reporting. Commun Dis Public Health 2004;7:73-6.